The therapeutic human CD38 antibody daratumumab improves the anti-myeloma effect of newly emerging multi-drug therapies

Spremljeno u:
Bibliografski detalji
Glavni autori: van der Veer, M S, de Weers, M, van Kessel, B, Bakker, J M, Wittebol, S, Parren, P W H I, Lokhorst, H M, Mutis, T
Format: Artigo
Jezik:Inglês
Izdano: Nature Publishing Group 2011
Teme:
Letter to the Editor
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3255255/
https://ncbi.nlm.nih.gov/pubmed/22829073
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bcj.2011.42
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items